Alliqua BioMedical Inc (ALQA):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Alliqua BioMedical Inc (ALQA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3423
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Alliqua BioMedical Inc (Alliqua BioMedical), formerly HepaLife Technologies Inc, is a regenerative technology company that builds a suite of regenerative solutions for wound and tissue repair. The company’s products comprise ultrasound healing therapy, human biologics, antimicrobial protection and hydration. Its contract manufacturing business unit provides custom hydrogels to the OEM market. Alliqua BioMedical develops and manufactures electron-beam cross-linked sheet gels for manufacturer of medical devices, cosmeceuticals, and other commercial product applications. The company’s customer service professionals assist with order placement, product training, and reimbursement. It operates through its GMP manufacturing facility in Langhorne. Alliqua BioMedical is headquartered in Langhorne, Pennsylvania, the US.

Alliqua BioMedical Inc (ALQA) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Alliqua BioMedical Inc, Medical Devices Deals, 2012 to YTD 2018 9
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Alliqua Enters Into Distribution Agreement With Sorbion 11
Licensing Agreements 12
Alliqua BioMedical Amends Licensing Agreement with Celgene Cellular Therapeutics 12
Alliqua BioMedical Amends Licensing Agreement with Celgene Cellular Therapeutics 13
Alliqua Enters Into Licensing Agreement With Celgene Cellular Therapeutics For Wound Care Products 14
Equity Offering 15
Alliqua BioMedical Raises USD2.8 Million in Private Placement of Shares 15
Alliqua Completes Private Placement Of Shares For US$15 Million 16
Alliqua Completes Private Placement Of Shares For US$5.3 Million Upon Exercise Of Warrants 17
Alliqua BioMedical Raises USD0.54 Million in Private Placement of Shares 18
Alliqua BioMedical Inc – Key Competitors 19
Alliqua BioMedical Inc – Key Employees 20
Alliqua BioMedical Inc – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Financial Announcements 22
Aug 10, 2017: Alliqua BioMedical Reports Second Quarter of Fiscal Year 2017 Financial Results 22
May 09, 2017: Alliqua BioMedical Reports First Quarter of Fiscal Year 2017 Financial Results 25
Apr 06, 2017: Alliqua BioMedical Announces Preliminary First Quarter Fiscal 2017 Revenue and Updates Fiscal Year 2017 Outlook 26
Mar 07, 2017: Alliqua BioMedical Reports Fourth Quarter and Fiscal Year 2016 Financial Results 27
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alliqua BioMedical Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Alliqua BioMedical Inc, Medical Devices Deals, 2012 to YTD 2018 9
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Alliqua Enters Into Distribution Agreement With Sorbion 11
Alliqua BioMedical Amends Licensing Agreement with Celgene Cellular Therapeutics 12
Alliqua BioMedical Amends Licensing Agreement with Celgene Cellular Therapeutics 13
Alliqua Enters Into Licensing Agreement With Celgene Cellular Therapeutics For Wound Care Products 14
Alliqua BioMedical Raises USD2.8 Million in Private Placement of Shares 15
Alliqua Completes Private Placement Of Shares For US$15 Million 16
Alliqua Completes Private Placement Of Shares For US$5.3 Million Upon Exercise Of Warrants 17
Alliqua BioMedical Raises USD0.54 Million in Private Placement of Shares 18
Alliqua BioMedical Inc, Key Competitors 19
Alliqua BioMedical Inc, Key Employees 20
Alliqua BioMedical Inc, Subsidiaries 21

List of Figures
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Alliqua BioMedical Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Alliqua BioMedical Inc (ALQA):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Embotelladora Andina SA (ANDINA-B):企業の財務・戦略的SWOT分析
    Embotelladora Andina SA (ANDINA-B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Oxiteno SA Industria E Comercio:企業の戦略的SWOT分析
    Oxiteno SA Industria E Comercio - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Hycor Biomedical Inc-医療機器分野:企業M&A・提携分析
    Summary Hycor Biomedical Inc (Hycor) is a medical device company that manufactures and markets in-vitro diagnostic products. The company offers products such as auto immune testing systems, allergy testing systems, HYTEC plus and HYCOR ultrasensitive EIA products. Its auto immune testing products co …
  • Instituto Costarricense de Electricidad:企業の戦略的SWOT分析
    Instituto Costarricense de Electricidad - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Lynntech Inc:企業の製品パイプライン分析
    Summary Lynntech Inc (Lynntech) is a diversified company. The company designs, fabricates and refines fuel cell test stations for research. It conducts research and development in the areas of energy, power, life sciences, materials science, therapeutics and diagnostics, chemical and environmental s …
  • ESI Group S.A. (ESI):企業の財務・戦略的SWOT分析
    ESI Group S.A. (ESI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Western Area Power Administration:企業の戦略的SWOT分析
    Western Area Power Administration - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • The Pep BoysManny, Moe & Jack:企業の戦略・SWOT・財務情報
    The Pep BoysManny, Moe & Jack - Strategy, SWOT and Corporate Finance Report Summary The Pep BoysManny, Moe & Jack - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Microsemi Corporation (MSCC):企業の財務・戦略的SWOT分析
    Microsemi Corporation (MSCC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Demant AS (DEMANT):企業の財務・戦略的SWOT分析
    Demant AS (DEMANT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Patrys Ltd (PAB)-製薬・医療分野:企業M&A・提携分析
    Summary Patrys Ltd (Patrys) is a healthcare company that provides therapeutic products. The company offers product pipeline such as PAT-SC1 used for the treatment of gastric cancer; PAT-SM6, PAT-PA1, and PAT-LM1 used to treat multiple cancers. It develops natural human antibody-based therapeutic pro …
  • Westside Corporation Pty Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Westside Corporation Pty Ltd (Westside) is an oil and gas company that explores and produces coal seam gas. The company provides gas seam projects such as Paranui ATP 769P, Meridian SeamGas CSG fields, Tilbrook ATP 688P, and Mount Saint Martin ATP 688P, among others. It offers Paranui ATP 76 …
  • Oriental Land Co., Ltd.:企業の戦略・SWOT・財務情報
    Oriental Land Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Oriental Land Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Wawa Inc:戦略・SWOT・企業財務分析
    Wawa Inc - Strategy, SWOT and Corporate Finance Report Summary Wawa Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Seven & i Holdings Co., Ltd.:企業の戦略・SWOT・財務分析
    Seven & i Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Seven & i Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Mississippi Power Co:企業の戦略的SWOT分析
    Mississippi Power Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Tec-Masters, Inc.:企業の戦略・SWOT・財務情報
    Tec-Masters, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tec-Masters, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Consumers Energy Company-エネルギー分野:企業M&A・提携分析
    Summary Consumers Energy Company (Consumers), formerly Consumers Power, is an electric and natural gas utility. The company generates purchases, transmits, distributes, and sells electricity. It also carries out the purchase, transmission, storage, distribution, and sale of natural gas. It generates …
  • Livzon Pharmaceutical Group Co Ltd (000513):企業の財務・戦略的SWOT分析
    Summary Livzon Pharmaceutical Group Co Ltd (Livzon) a subsidiary of Joincare Pharmaceutical Group Industry Co Ltd, is a pharmaceutical company which is engaged in developing, manufacturing and distributing pharmaceutical products. The company provides preparation drug products, bulk medicines and in …
  • Beijing Shouhang IHW Resources Saving Technology Co Ltd (002665):電力:M&Aディール及び事業提携情報
    Summary Beijing Shouhang IHW Resources Saving Technology Co Ltd (Shouhang IHW Resources) is an electrical equipment company that offers heat generation systems. The company designs, manufactures and distributes CSP power generating system, thermal power plant air cooling system, waste heat power gen …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆